OR56B3P

Across TCGA pan-cancer cohorts, OR56B3P RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated OR56B3P data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher OR56B3P RNA is associated with better overall survival. In most high-consensus cancer types, elevated OR56B3P expression acts as an unfavorable survival marker, although some lineages such as BLCA and PRAD show a favorable association.

BLCA, READ, and TGCT are the cancer types where OR56B3P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Tertile	II,III,IV	0.818	0.581	.002	78	view →
READ	OS	Tertile	All	0.164	0.703	<.001	54	view →
TGCT	DFS	Tertile	II,III,IV	0.015	0.919	<.001	48	view →
COAD	OS	Tertile	III,IV	0.176	0.698	.008	42	view →
LUSC	DFS	Tertile	II,III,IV	0.392	0.613	.021	36	view →
PAAD	DFS	Tertile	III,IV	0.118	0.734	.014	18	view →
PRAD	DFS	Tertile	All	1.000	0.926	.021	18	view →
LUAD	DFS	Tertile	IV	1.000	0.285	.042	15	view →
BRCA	DFS	Tertile	II,III,IV	0.379	0.534	.016	12	view →
GBM	OS	Tertile	All	0.089	0.415	.021	9	view →
THCA	DFS	Tertile	IV	0.027	0.937	<.001	9	view →
LAML	DFS	Tertile	All	0.464	0.632	.018	8	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 13 lineages.

OR56B3P–BLCA (OS)

Open the BLCA breakdown →